Gene therapy for neovascular age-related macular degeneration: rationale, clinical trials and future directions

Age-related macular degeneration (AMD) is one of the leading causes of irreversible blindness in the developed world. Antivascular endothelial growth factor therapy has transformed the management and outcome of neovascular AMD (nAMD), although the need for repeated intravitreal injections—even lifel...

Descripción completa

Detalles Bibliográficos
Autores principales: de Guimaraes, Thales Antonio Cabral, Georgiou, Michalis, Bainbridge, James W B, Michaelides, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848059/
https://www.ncbi.nlm.nih.gov/pubmed/32269060
http://dx.doi.org/10.1136/bjophthalmol-2020-316195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848059/
https://www.ncbi.nlm.nih.gov/pubmed/32269060
http://dx.doi.org/10.1136/bjophthalmol-2020-316195

Ejemplares similares